At a glance
ClinicalIndex Comparison RecordN/ACompleted· 439 enrolled
Drug / intervention
Dilapan-Sdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
International Observational E-Registry on the Use of Dilapan-S/Dilasoft Osmotic Dilators for Cervical Priming Prior to Induced Abortion
In Brief
An observational study evaluating Dilapan-S for Abortion, Induced. Completed, enrolled 439 participants.
Detailed Summary
International Observational E-Registry on the use of osmotic dilators DILAPAN-S® / DILASOFT® for cervical priming prior to induced abortion.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAbortion, Induced
Countries--
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 2014
Enrollment StartMar 2015
Primary CompletionDec 2016
TodayJul 2026
First PostedDec 17, 2014
Enrollment StartMar 1, 2015
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 11.5 years ago
Interventions
Dilapan-Sdevice
Synthetic osmotic dilators Dilapan-S or Dilasoft for cervical priming prior to induced abortion